F8N-10089-79286
2 vaccinations
7 coded responses
24 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 549 / WI
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Registered in v-safe
-
2021-02-18
Dose 1 — Moderna
- 2021-02-18
- 2021-02-19
- 2021-02-20
- 2021-02-21
- 2021-02-22
- 2021-02-23
- 2021-02-24
- 2021-02-25
-
2021-03-04
Survey response — day 14, dose 1MedDRA: Injection site bruising, Injection site erythema — Feeling: GoodFree text: Red, bruised appearance at injection site itched at day 5 for about a day.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-11
-
2021-03-18
Dose 2 — Moderna
-
2021-03-18
Survey response — day 0, dose 2MedDRA: Injection site discolouration — Feeling: Good · Site: RednessFree text: Area of shot also has a dark area, like 1.5 inch diameter. I got this after a couple days after the first shot and it lasted 3 weeks.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-19
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: RednessFree text: Site of shot looks like a bruise, but its not. This happened on shot 1.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-20
Survey response — days 1–6 daily, dose 2MedDRA: Injection site bruising — Feeling: Good · Site: RednessFree text: Bruised look, but not sore at sight of shotMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-21
Survey response — days 1–6 daily, dose 2MedDRA: Injection site discolouration — Feeling: Good · Site: RednessFree text: Dark area at shot site.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-26
- 2021-04-01
- 2021-04-08
-
2021-04-15
Survey response — day 28, dose 2MedDRA: Oropharyngeal pain — Feeling: FairFree text: Was fine up to today. Have a slight sore throat and a little neurolia in my head and ears.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-01
- 2021-06-18
-
2022-03-18
Survey response — 12 months, dose 2MedDRA: COVID-19, Nasopharyngitis, SARS-CoV-2 test negative, SARS-CoV-2 test positive — Feeling: GoodFree text: Had covid in early January 2022. Got tested at height of symptoms, received a negative test. Retested before an event when symptoms were pretty much over, and tested positive. Have fullt recovered now. Symptoms were like a cold.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Moderna | |
| 2 | 2021-03-18 | Moderna |
Free text
Release 5 — day 14, dose 1
Symptoms: Red, bruised appearance at injection site itched at day 5 for about a day.
Release 5 — day 0, dose 2
Systemic reaction (other): Area of shot also has a dark area, like 1.5 inch diameter. I got this after a couple days after the first shot and it lasted 3 weeks.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Site of shot looks like a bruise, but its not. This happened on shot 1.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): Bruised look, but not sore at sight of shot
Systemic reaction (other): Dark area at shot site.
Release 7 — day 28, dose 2
Symptoms: Was fine up to today. Have a slight sore throat and a little neurolia in my head and ears.
Release 11 — 12 months, dose 2
Symptoms: Had covid in early January 2022. Got tested at height of symptoms, received a negative test. Retested before an event when symptoms were pretty much over, and tested positive. Have fullt recovered now. Symptoms were like a cold.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site bruising | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site discolouration | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release